IL116776A - Acylated bicyclic (di)azepine vasopressin and oxytocin antagonists and their preparation - Google Patents

Acylated bicyclic (di)azepine vasopressin and oxytocin antagonists and their preparation

Info

Publication number
IL116776A
IL116776A IL11677696A IL11677696A IL116776A IL 116776 A IL116776 A IL 116776A IL 11677696 A IL11677696 A IL 11677696A IL 11677696 A IL11677696 A IL 11677696A IL 116776 A IL116776 A IL 116776A
Authority
IL
Israel
Prior art keywords
vasopressin
azepine
preparation
oxytocin antagonists
acylated
Prior art date
Application number
IL11677696A
Other languages
English (en)
Other versions
IL116776A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL116776A0 publication Critical patent/IL116776A0/xx
Publication of IL116776A publication Critical patent/IL116776A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11677696A 1995-01-17 1996-01-16 Acylated bicyclic (di)azepine vasopressin and oxytocin antagonists and their preparation IL116776A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/373,839 US5696112A (en) 1995-01-17 1995-01-17 Fused heterocyclic azepines as vasopressin antagonists

Publications (2)

Publication Number Publication Date
IL116776A0 IL116776A0 (en) 1996-05-14
IL116776A true IL116776A (en) 2000-10-31

Family

ID=23474102

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11677696A IL116776A (en) 1995-01-17 1996-01-16 Acylated bicyclic (di)azepine vasopressin and oxytocin antagonists and their preparation

Country Status (23)

Country Link
US (2) US5696112A (ja)
EP (1) EP0811008B1 (ja)
JP (1) JPH10512572A (ja)
KR (1) KR19980703098A (ja)
CN (1) CN1177356A (ja)
AR (1) AR010195A1 (ja)
AT (1) ATE251166T1 (ja)
AU (1) AU716008B2 (ja)
BR (1) BR9607153A (ja)
CA (1) CA2210571A1 (ja)
CZ (1) CZ224697A3 (ja)
DE (1) DE69630209T2 (ja)
DK (1) DK0811008T3 (ja)
EA (1) EA001427B1 (ja)
ES (1) ES2207672T3 (ja)
HU (1) HUP9800466A3 (ja)
IL (1) IL116776A (ja)
MX (1) MX9705312A (ja)
NZ (1) NZ302119A (ja)
PT (1) PT811008E (ja)
TW (1) TW342385B (ja)
WO (1) WO1996022294A1 (ja)
ZA (1) ZA96298B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7338796A (en) * 1995-11-09 1997-05-29 Japan Tobacco Inc. Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US6977254B2 (en) * 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
MXPA03009158A (es) * 2001-04-12 2004-02-12 Wyeth Corp Azepinas y diazepinas bi y triciclicas substituidas de n-bifenilcarbonil y n-fenilpiridilcarbonil como agonistas de la vasopresion.
US7053083B2 (en) * 2001-04-12 2006-05-30 Wyeth Cyclohexylphenyl vasopressin agonists
US7202239B2 (en) * 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7326700B2 (en) * 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
CA2636826C (en) 2006-01-18 2011-11-29 F.Hoffmann-La Roche Ag Thiazoles as 11 beta-hsd1 inhibitors
JP5690286B2 (ja) * 2009-03-04 2015-03-25 イデニク プハルマセウティカルス，インコーポレイテッド ホスホチオフェン及びホスホチアゾールｈｃｖポリメラーゼ阻害剤
AR076221A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2017175000A1 (en) 2016-04-08 2017-10-12 Pulmocide Limited Compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821020B (en) * 1981-02-18 1983-10-26 Thomae Gmbh Dr K Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
DE69009785T2 (de) * 1989-02-10 1994-11-03 Otsuka Pharma Co Ltd Carbostyrilderivate.
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
WO1991005549A1 (en) * 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (ja) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
TW198715B (ja) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533243B1 (en) * 1991-09-16 1997-12-17 Merck & Co. Inc. Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives
US5204349A (en) * 1991-09-16 1993-04-20 Merck & Co., Inc. Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0612319A1 (en) * 1992-08-20 1994-08-31 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
TW270927B (ja) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
AU5533894A (en) * 1992-11-25 1994-06-22 Yamanouchi Pharmaceutical Co., Ltd. Benzanilide derivative
AU5692094A (en) * 1992-12-21 1994-07-19 Yamanouchi Pharmaceutical Co., Ltd. Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor
AU6219994A (en) * 1993-03-11 1994-09-26 Yamanouchi Pharmaceutical Co., Ltd. Compound with vasopressin antagonism
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
JPH10512572A (ja) 1998-12-02
EP0811008A1 (en) 1997-12-10
DE69630209D1 (de) 2003-11-06
BR9607153A (pt) 1997-11-11
EA199700115A1 (ru) 1997-12-30
AR010195A1 (es) 2000-06-07
AU4770696A (en) 1996-08-07
US5696112A (en) 1997-12-09
KR19980703098A (ko) 1998-10-15
ATE251166T1 (de) 2003-10-15
HUP9800466A3 (en) 1998-12-28
ES2207672T3 (es) 2004-06-01
CZ224697A3 (cs) 1998-01-14
PT811008E (pt) 2004-02-27
AU716008B2 (en) 2000-02-17
CA2210571A1 (en) 1996-07-25
CN1177356A (zh) 1998-03-25
TW342385B (en) 1998-10-11
HUP9800466A2 (hu) 1998-07-28
EA001427B1 (ru) 2001-02-26
IL116776A0 (en) 1996-05-14
US5654297A (en) 1997-08-05
DE69630209T2 (de) 2004-08-19
MX9705312A (es) 1997-10-31
WO1996022294A1 (en) 1996-07-25
DK0811008T3 (da) 2004-01-26
EP0811008B1 (en) 2003-10-01
NZ302119A (en) 2000-02-28
ZA96298B (en) 1997-07-15

Similar Documents

Publication Publication Date Title
IL116776A (en) Acylated bicyclic (di)azepine vasopressin and oxytocin antagonists and their preparation
IL116777A (en) Tricyclic benzazepine vasopressin and oxytocin antagonists their preparation and pharmaceutical compositions containing them
HK1004132A1 (en) Tricyclic benzazepine vasopressin antagonists
ZA96303B (en) Tricyclic benzazepine vasopressin antagonists
ZA96300B (en) Tricyclic benzazepine vasopressin antagonists
ZA96299B (en) Tricyclic benzazepine vasopressin antagonists
HUP9900331A2 (hu) Indolin-2-on-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
IL123258A0 (en) Opioid peptides
IL112243A (en) Benzazepine and benzodiazepine fribinogen antagonists a process for their preparation and pharmaceutical compositions containing them
HU9602550D0 (en) Gnrh antagonists
AU5593094A (en) Bicyclic gnrh antagonists
EP0729472A4 (en) OXYTOCIN ANTAGONISTS COMPRISING PIPERIDINYLCAMPHOSULFONYL
AU3641497A (en) Tricyclic benzazepine vasopressin antagonists
IL118299A0 (en) Pharmacological use of AII-receptor antagonists
AU3296597A (en) Tricyclic benzazepine vasopressin antagonists
IL108509A0 (en) GnRH antagonist peptides
AU3296497A (en) Tricyclic benzazepine vasopressin antagonists
IL114046A0 (en) New opioid peptide antagonists
SI0804438T1 (sl) Triciklicni benzazepinski antagonisti vazopresina
GB9306489D0 (en) Oxytocin antagonists
IL113441A0 (en) Opioid peptide analoog
AU4974596A (en) Betide-substituted gnrh antagonists
ZA88964B (en) Oxytocin and vasopressin antagonists
IL119412A0 (en) Gonadotropins and pharmaceutical compositions containing them
SI0873309T1 (en) 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees